Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A. [electronic resource]
Producer: 20020405Description: 254-61 p. digitalISSN:- 1525-4135
- AIDS Vaccines -- adverse effects
- Adult
- Double-Blind Method
- Female
- HIV Antibodies -- blood
- HIV Envelope Protein gp120 -- adverse effects
- HIV Infections -- diagnosis
- HIV Seronegativity -- immunology
- HIV-1 -- immunology
- Humans
- Immunization Schedule
- Male
- Neutralization Tests
- Recombinant Proteins -- adverse effects
- T-Lymphocytes, Cytotoxic -- immunology
- Vaccines, Combined
- Vaccines, Synthetic
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.